Xeris Biopharma Holdings, Inc. (XERS)

$6.93 +3.28%

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-07 APPROXIMATE

Since Nov 10, 2021, Xeris Biopharma Holdings, Inc. (XERS) has reported earnings 19 times. On average the shares move ±9.03% post-earnings, with a positive reaction 57.9% of the time. Its largest post-earnings gain was +20.22% (Aug 07, 2025) and its largest decline was -21.88% (Nov 06, 2025). The next earnings report is predicted for 2026-08-07 (approximate).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±9.03%

Positive %

57.9%

Negative %

42.1%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
May 07, 2026	☀ PRE	$6.62	$7.00	$6.63	286,595	+4%	open_in_new
Mar 02, 2026	☀ PRE	$7.08	$7.12	$6.02	5,108,500	-1.63%	open_in_new
Nov 06, 2025	☀ PRE	$8.40	$8.95	$7.71	10,591,200	-21.88%	open_in_new
Aug 07, 2025	☀ PRE	$6.73	$7.09	$6.60	10,175,500	+20.22%	open_in_new
May 08, 2025	☀ PRE	$4.47	$5.28	$5.16	5,209,500	+15.18%	open_in_new
Mar 06, 2025	☀ PRE	$4.14	$4.50	$4.13	9,650,900	+9.55%	open_in_new
Nov 08, 2024	☀ PRE	$3.40	$3.64	$3.47	6,684,000	+3.27%	open_in_new
Aug 08, 2024	☀ PRE	$2.24	$2.39	$2.23	3,132,200	+4.69%	open_in_new
May 09, 2024	☀ PRE	$1.85	$1.89	$1.88	1,611,700	+1.62%	open_in_new
Mar 06, 2024	☀ PRE	$3.04	$3.04	$2.48	8,388,800	-19.48%	open_in_new
Nov 09, 2023	☀ PRE	$2.07	$2.18	$1.81	3,004,300	-8.59%	open_in_new
Aug 08, 2023	☀ PRE	$2.42	$2.78	$2.58	1,753,500	+3.61%	open_in_new
May 09, 2023	☀ PRE	$2.45	$2.73	$2.73	3,232,400	+13.75%	open_in_new
Mar 08, 2023	☀ PRE	$1.51	$1.52	$1.35	1,930,800	-11.76%	open_in_new
Nov 09, 2022	☀ PRE	$1.62	$1.62	$1.48	1,075,800	-1.33%	open_in_new
Aug 10, 2022	☀ PRE	$1.73	$1.96	$1.93	1,437,500	+13.53%	open_in_new
May 11, 2022	☀ PRE	$1.86	$1.86	$1.64	2,623,700	-8.38%	open_in_new
Mar 10, 2022	☀ PRE	$2.35	$2.69	$2.62	3,832,400	+6.07%	open_in_new
Nov 10, 2021	☀ PRE	$1.93	$2.00	$1.90	1,765,100	-3.06%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±9.03%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260605	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov
4	20260605	open_in_new SEC.gov
8-K	20260605	open_in_new SEC.gov
144	20260604	open_in_new SEC.gov
144	20260604	open_in_new SEC.gov
144	20260604	open_in_new SEC.gov

Frequently asked about XERS earnings

When does Xeris Biopharma Holdings, Inc. report earnings next? expand_more

Xeris Biopharma Holdings, Inc. (XERS)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does XERS stock move after earnings? expand_more

Over 19 reports, XERS has moved an average of ±9.03% the session after earnings, closing higher 57.9% of the time.

What was XERS's biggest post-earnings move? expand_more

XERS's largest post-earnings gain on record was +20.22% on Aug 07, 2025, and its largest decline was -21.88% on Nov 06, 2025.

Where can I find Xeris Biopharma Holdings, Inc.'s SEC filings? expand_more

All of Xeris Biopharma Holdings, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.